
Medtronic PLC MDT
$ 96.18
-0.51%
Quarterly report 2025-Q3
added 11-25-2025
Medtronic PLC Interest Expense 2011-2025 | MDT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Medtronic PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 402 M | 412 M | 515 M | 553 M | 925 M | 1.09 B | 1.44 B | 1.15 B | 1.09 B | 1.39 B | 666 M | 379 M | 388 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 B | 379 M | 800 M |
Quarterly Interest Expense Medtronic PLC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92 M | 33 M | - | 72 M | 173 M | 157 M | - | 177 M | 154 M | 76 M | - | 167 M | 118 M | 164 M | - | 143 M | 136 M | 273 M | - | 156 M | 470 M | 470 M | 171 M | 243 M | 165 M | 165 M | 609 M | 270 M | 241 M | 241 M | 242 M | 268 M | 273 M | 273 M | 286 M | 275 M | 264 M | 264 M | 272 M | 176 M | 324 M | 324 M | 306 M | - | 94 M | 97 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 609 M | 33 M | 222 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
24.9 M | $ 21.04 | 0.86 % | $ 3.01 B | ||
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.39 | 0.97 % | $ 674 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.54 | 2.91 % | $ 123 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 95.46 | -0.55 % | $ 140 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 302.69 | -0.7 % | $ 8.54 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Electromed
ELMD
|
78 K | $ 29.28 | 1.1 % | $ 248 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 47.37 | -0.29 % | $ 7.06 K | ||
|
Abbott Laboratories
ABT
|
376 M | $ 125.42 | -0.31 % | $ 218 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.29 | 2.34 % | $ 123 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.43 | -0.35 % | $ 1.23 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 61.42 | -1.39 % | $ 3.33 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.65 | 0.17 % | $ 134 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 156.53 | -1.02 % | $ 11.7 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.82 | 2.08 % | $ 84.3 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 13.5 | -0.52 % | $ 365 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.58 | -0.13 % | $ 122 M | ||
|
AxoGen
AXGN
|
-199 K | $ 32.74 | 0.03 % | $ 1.45 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.65 | -1.2 % | $ 1.25 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.74 | -1.25 % | $ 409 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 87.52 | -0.4 % | $ 11.9 B | ||
|
Orthofix Medical
OFIX
|
-9.62 M | $ 15.16 | -1.11 % | $ 578 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.42 | -2.09 % | $ 956 M |